PIN17 Pharmacoeconomic Analysis of Antiretroviral Therapy (ART) Based on Local D?ta from Real Clinical Practice, and Modeling Changes in Approaches to the HIV Treatment in the Russian Federation

2021 ◽  
Vol 24 ◽  
pp. S108
Author(s):  
A. Kolbin ◽  
I. Velum ◽  
Y. Balykina ◽  
M. Proskurin
Keyword(s):  
Clinical Practice ◽  
Antiretroviral Therapy ◽  
Russian Federation ◽  
Pharmacoeconomic Analysis ◽  
Hiv Treatment ◽  
The Russian Federation ◽  
Real Clinical Practice

scholarly journals Atrial fibrillation treatment in Russia: work on bugs

2021 ◽  
Vol 28 (3) ◽  
pp. 1-4
Author(s):  
S. G. Kanorskii
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Russian Federation ◽  
Medical Errors ◽  
Clinical Guidelines ◽  
The Future ◽  
The Russian Federation ◽  
Real Clinical Practice

The article discusses the results of a survey of doctors in the Russian Federation with the aim of studying approaches to the treatment of atrial fibrillation in real clinical practice and comparing the results obtained with the current clinical guidelines. Some new data are presented that could change the recommendations in the future; possible causes of medical errors and ways to correct them are discussed.

Problems and prospects for the implementation of pharmacogenetic testing in real clinical practice in the Russian Federation

2020 ◽  
pp. 6-12
Author(s):  
Regina Nasyrova ◽  
Vera Dobrodeeva ◽  
Stanislav Skopin ◽  
Nataliya Shnayder ◽  
Nikolay Neznanov
Keyword(s):  
Quality Of Life ◽  
Clinical Practice ◽  
Russian Federation ◽  
Pharmacogenetic Testing ◽  
Current State ◽  
Pharmacological Response ◽  
The Russian Federation ◽  
Personalized Approach ◽  
Real Clinical Practice

The article discusses the current state of the use of pharmacogenetic testing in clinical practice in the field of psychiatry, narcology and neurology in the Russian Federation. The active introduction of pharmacogenetic testing in clinical practice contributes to a personalized approach to predicting the pharmacological response to drugs, increasing the safety and effectiveness of pharmacotherapy, complience and the quality of life of patients with neuropsychiatric disorders. In the future, an increase in the availability of pharmacogenetic testing in real clinical practice is expected.

scholarly journals Principles of organization of medical care for patients with heart failure in the system of cardiovascular risk management: focus on continuity of care and patient routing. Practical materials

2021 ◽  
Vol 26 (3S) ◽  
pp. 4558 ◽  
Author(s):  
S. V. Villevalde ◽  
A. E. Soloveva ◽  
N. E. Zvartau ◽  
N. G. Avdonina ◽  
A. N. Yakovlev ◽  
...  
Keyword(s):  
Heart Failure ◽  
Risk Management ◽  
Clinical Practice ◽  
Cardiovascular Risk ◽  
Medical Care ◽  
Optimal Model ◽  
Cardiovascular Risk Management ◽  
Patients With Heart Failure ◽  
The Russian Federation ◽  
Real Clinical Practice

The extent of the problem of heart failure determines the priority of the intention of developing and implementing an optimal model of medical care for this group of patients. The article describes the key components of the heart failure medical care (continuity, patient routing, educational activities) and provides examples of documents, protocols, checklists that can be used in real clinical practice by specialists in medical organizations in the regions of the Russian Federation.

scholarly journals EVALUATION OF THE CLINICAL AND ECONOMIC EFFECTIVENESS OF INTERFERON-GAMMA IN THE TREATMENT OF TUBERCULOSIS

2017 ◽  
Vol 22 (6) ◽  
pp. 276-280
Author(s):  
S. L Plavinskiy ◽  
Pavel I. Shabalkin
Keyword(s):  
Quality Of Life ◽  
Drug Resistance ◽  
Economic Evaluation ◽  
Health System ◽  
Interferon Gamma ◽  
Russian Federation ◽  
Pharmacoeconomic Analysis ◽  
Treatment Regimens ◽  
The Russian Federation

Tuberculosis worldwide is a serious problem for the health system and for society. Despite the fact that in recent years there has been a tendency to the decline in the incidence of tuberculosis, it remains to be one of the socially significant infections in the Russian Federation. Significant difficulties in the treatment of tuberculosis include the overcoming of the drug resistance of mycobacteria to the existing therapy, as well as the available limitations of the resources of the healthcare system in the Russian Federation. In this regard, there is a need to find additional opportunities to improve the effectiveness of the treatment and clinical and economic evaluation of existing treatment regimens. Interferon-gamma is an effective preparation for the management of tuberculosis. As a result of the pharmacoeconomic analysis, the administration of interferon-gamma (Ingaron) contributed to an increase in the quality of life by 2.1 QALY, and in terms of an addition to the therapy will be accompanied by savings of the budget of the Russian Federation up to 284 million rubles, or up to 27.3% of funds for the treatment of patients from this group.

scholarly journals Tactical approaches to the treatment of arterial hypertension in the European part of the Russian Federation. EPOHA study 2017

Kardiologiia ◽  
2019 ◽  
Vol 59 (11S) ◽  
pp. 77-84
Author(s):  
Yu. V. Badin
Keyword(s):  
Arterial Hypertension ◽  
Antihypertensive Therapy ◽  
Russian Federation ◽  
Antihypertensive Treatment ◽  
Antihypertensive Drugs ◽  
European Part ◽  
Frequency Of Use ◽  
Two Component ◽  
The Russian Federation ◽  
Real Clinical Practice

Aim. Analysis of antihypertensive treatment among different groups of patients with arterial hypertension from “EPOCHA” study 2017. Materials and methods. EPOCHA study is a representative sample of the European part of the Russian Federation was created in 2002 and re-examined in 2017. Results. 34.6% of the effectively treated (ET) patients had one antihypertensive drug and 32,2% of the ineffective treatment (IT) patients, p=0.16. Two-component antihypertensive therapy was 45.9% and 44.9%, respectively, p=0.56. Three antihypertensive drugs had 17.9% of the ET patients and 20.7% of the IT patients, p=0.05. Four antihypertensive drugs had 1.6% of the ET patients and 2.2% of the IT patients. The frequency of use of renin-angiotensin-aldosterone system blockers in the group of ET patients was 85.0%, which was significantly lower than 91.6% in the group of IT patients, р<0.0001. Conclusion. EPOCHA study shows that structure of antihypertensive therapy does not differ between ET and IT patients what is caused lack of medical supervision for patients with hypertension in real clinical practice.

Sign in / Sign up

Export Citation Format

Share Document